Supplier of Compound Ringer Lactate and Glucose Injection

China Supplier of Compound Ringer Lactate and Glucose Injection, Find details about China Sodium Lactate, Injection from Supplier of Compound Ringer Lactate and Glucose Injection

Model NO.
500ml
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
20045842
Production Line
GMP Approved
Trademark
SHIMEN
Transport Package
Carton
Specification
500ml 1000ml
Origin
Hebei
HS Code
3004909099
Model NO.
500ml
Pharmaceutical Technology
Chemical Synthesis
Drug Reg./Approval No.
20045842
Production Line
GMP Approved
Trademark
SHIMEN
Transport Package
Carton
Specification
500ml 1000ml
Origin
Hebei
HS Code
3004909099
Compound Sodium lactate and Glucose Injection
 
Product name: Compound Sodium Lactate and Glucose Injection
Main ingredients and chemical name: every 1000ml contain: Sodium Lactate 3.10g,   sodium chloride 6.00g, potassium chloride 0.30g, Calcium chloride (CaCl2·2H2O) 0.20g and Glucose Anhydrous 50.0g.
Character The product is a colorless or light yellow clear liquid.
Pharmacology and toxicity It can adjust the body liquid volume and osmosis pressure, supplement the ion of potassium, sodium calcium and chloride, and supply the heart. Sodium lactate will be turned into bicarbonate ion to adjust the balance of acid and alkalis and keep the normal physiological function; sodium is the most important positive ion in the extracellular fluid, and it is the main substance to keep the body liquid constant osmosis and volume; potassium is main positive ion in the cellula, it is important to keep the normal nerve muscle excitability; Calcium ion is the second messenger in the cellula and who is related with many body functions closely. Glucose is to supply the heat, lactate ion is to correct metabolic acidoxix and help potassium ion enter into the cellula from blood and extracelllar fluid. When the volume of blood and tissue liquid decrease, it can be taken as the supplementary and adjustment substance to correct the electrolyte disorder and acidoxis.


Shijiazhuang No.4 Pharmaceutical Co., Ltd. was established in 1948, now it is a large-sized foreign invested enterprise and comprehensive medicine manufacturer in China, the capital is USD58 million, and with more than 3000 employees. The company can manufacture 7 series medicines of more than 100 kinds and specifications including infusions, capsules, granules, tablets, oral liquids and etc with GMP approval by SFDA of China. For the key product of large volume I.V solution, the yearly output has reached more than 1200 million bottles including 40 million bottles packing with the soft plastic bottles in the dosage of 500 ml/ 250 ml /100ml. Some index such as quality, variety, and yearly output are all in the leading position of this field in China.